2023 Ukraine Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
-
Report Description
- Table of Contents
- FAQs
Table of Contents
I.Introduction
II.Worldwide Market Overview
III.Major Product Development Opportunities
A.Reagent Kits and Test Systems/Panels
B.Instrumentation
C.Computers, Software and Automation
D.Auxiliary Products
IV.Design Criteria for Decentralized Testing Products
V.Alternative Market Penetration Strategies
A.Internal Development
B.Collaborative Arrangements
C.University Contracts
D.Distribution Strategies
VI.Potential Market Entry Barriers and Risks
A.Market MaturityB.Cost ContainmentC.Competition
D.Technological Edge and Limitations
E.Patent Protection
F.Regulatory Constraints
G.Decentralized Testing Market Challenges
VII.Worldwide Market and Technology Overview
A.Breast Cancer Statistics and Etiology
B. Breast Cancer Diagnostic Tests
1.CEA
2.CA 15-3
3.CA 27.29
4.CA 125
5.Estrogen Receptor
6.HER2
7.Polypeptide-Specific Antigen
8.Progesterone Receptor
C.Cancer Diagnostic Testing Instrumentation Review and Market Needs
D.Current and Emerging Cancer Diagnostic Technologies
1.Monoclonal and Polyclonal Antibodies
2.Immunoassays
3.Molecular Diagnostics
4.Chromosome Analysis
a.Chronic Myelogenous Leukemia (CML)
b.Acute Myeloid Leukemia (AML)
c.Acute Lymphoblastic Leukemia (ALL)
d.Malignant Lymphomas Lymphoid Malignancies
e.Chronic Lymphocytic Leukemia (CLL)
f.Solid Cancers
g.Chromosomal Translocation and Oncogenes
5.Artificial Intelligence
6.Flow Cytometry
7.Two Dimensional Gel Electrophoresis (2-DGE)
8.Biosensors
9.Competing/Complementing Technologies
E.Personal Testing
VIII. Country Market Analysis: Breast Cancer Diagnostics Market Test Volume and Sales Forecasts
IX.Competitive Profiles
The report provides strategic assessments of over 30 cancer diagnostics market players and start-up companies with innovative technologies and products, including:
-Abbott
-Affymetrix
-Becton Dickinson
-bioMerieux
-Bio-Rad
-Danaher/Beckman Coulter/Cepheid
-DiaSorin
-Eiken Chemical
-Elitech Group
-Enzo Biochem
-Fujifilm Wako
-Fujirebio
-Grifols
-Hologic
-Leica Biosystems
-Qiagen
-QuidelOrtho
-Roche
-Siemens Healthineers
-Takara Bio
-Thermo Fisher
List of Tables
Major Companies Developing or Marketing CA 15-3 Tests
Major Companies Developing or Marketing CA 27.29 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing HER2 Tests
Major Companies Developing or Marketing Polypeptide-Specific Antigen Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Breast Cancer Diagnostic Volume Forecasts by Test
Breast Cancer Diagnostics Sales Forecasts by Test
Breast Cancer Market by Major Supplier
I.Introduction
II.Worldwide Market Overview
III.Major Product Development Opportunities
A.Reagent Kits and Test Systems/Panels
B.Instrumentation
C.Computers, Software and Automation
D.Auxiliary Products
IV.Design Criteria for Decentralized Testing Products
V.Alternative Market Penetration Strategies
A.Internal Development
B.Collaborative Arrangements
C.University Contracts
D.Distribution Strategies
VI.Potential Market Entry Barriers and Risks
A.Market MaturityB.Cost ContainmentC.Competition
D.Technological Edge and Limitations
E.Patent Protection
F.Regulatory Constraints
G.Decentralized Testing Market Challenges
VII.Worldwide Market and Technology Overview
A.Breast Cancer Statistics and Etiology
B. Breast Cancer Diagnostic Tests
1.CEA
2.CA 15-3
3.CA 27.29
4.CA 125
5.Estrogen Receptor
6.HER2
7.Polypeptide-Specific Antigen
8.Progesterone Receptor
C.Cancer Diagnostic Testing Instrumentation Review and Market Needs
D.Current and Emerging Cancer Diagnostic Technologies
1.Monoclonal and Polyclonal Antibodies
2.Immunoassays
3.Molecular Diagnostics
4.Chromosome Analysis
a.Chronic Myelogenous Leukemia (CML)
b.Acute Myeloid Leukemia (AML)
c.Acute Lymphoblastic Leukemia (ALL)
d.Malignant Lymphomas Lymphoid Malignancies
e.Chronic Lymphocytic Leukemia (CLL)
f.Solid Cancers
g.Chromosomal Translocation and Oncogenes
5.Artificial Intelligence
6.Flow Cytometry
7.Two Dimensional Gel Electrophoresis (2-DGE)
8.Biosensors
9.Competing/Complementing Technologies
E.Personal Testing
VIII. Country Market Analysis: Breast Cancer Diagnostics Market Test Volume and Sales Forecasts
IX.Competitive Profiles
The report provides strategic assessments of over 30 cancer diagnostics market players and start-up companies with innovative technologies and products, including:
-Abbott
-Affymetrix
-Becton Dickinson
-bioMerieux
-Bio-Rad
-Danaher/Beckman Coulter/Cepheid
-DiaSorin
-Eiken Chemical
-Elitech Group
-Enzo Biochem
-Fujifilm Wako
-Fujirebio
-Grifols
-Hologic
-Leica Biosystems
-Qiagen
-QuidelOrtho
-Roche
-Siemens Healthineers
-Takara Bio
-Thermo Fisher
List of Tables
Major Companies Developing or Marketing CA 15-3 Tests
Major Companies Developing or Marketing CA 27.29 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing HER2 Tests
Major Companies Developing or Marketing Polypeptide-Specific Antigen Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Breast Cancer Diagnostic Volume Forecasts by Test
Breast Cancer Diagnostics Sales Forecasts by Test
Breast Cancer Market by Major Supplier
Published By :Venture Planning Group